Q-omics provides the consensus-scored KIAA0895 profile across patient tissues and cancer cell-line models. KIAA0895 expression is associated with patient survival in 25 of 34 cancer types, with the highest sampling consensus in KIRC. Among the 18 cancer types available for tumor–normal comparison, KIAA0895 is differentially expressed in 14, with the highest sampling consensus in KICH. Additionally, KIAA0895 RNA expression shows 19,792 significant gene co-expression associations, with the highest sampling consensus in THYM. Together, these results highlight KIRC, KICH, and THYM as cancer lineages where KIAA0895 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for KIAA0895 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes KIAA0895 survival associations across molecular data types. KIAA0895 RNA expression shows survival associations in the most cancer types (25), followed by mutation status (2). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible KIAA0895 RNA expression–survival associations across cancer types. High KIAA0895 expression shows unfavorable associations in BLCA, LGG, KICH and CESC, but favorable associations in KIRC and SKCM. The KIRC Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p < 0.001). Together, the overview and detailed table identify KIRC as the clearest survival context for KIAA0895 RNA expression.
This table summarizes KIAA0895 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 14. The strongest signals are observed in KICH for RNA.
This table ranks reproducible tumor–normal expression differences for KIAA0895. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. KIAA0895 shows lower tumor expression in KICH, THCA and KIRC and higher tumor expression in COAD, HNSC and BLCA. The KICH box plot shows higher KIAA0895 RNA expression in normal versus tumor tissue (log2 FC = −2.750, t-test p < 0.001).
This table shows molecular features associated with KIAA0895 in patient tissues and cancer cell lines. In patient samples, KIAA0895 shows the broadest associations at the RNA and protein expression levels, with THYM recurring as the lineage with the largest associated feature set. In cancer cell lines, KIAA0895 RNA and mutation anchors are most strongly linked to RNA-expression features, especially in CNS, while CRISPR and shRNA rows add functional-dependency signals in LIVER and BLOOD_Leukemia.
